Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Apellis raises $47.1M series D round

    Apellis Pharmaceuticals Inc. (Crestwood, Ky.) raised $47.1 million in a series D round less than a week after it formally withdrew a proposed IPO on NASDAQ. Apellis is developing compounds that target complement 3 (C3) …

    Published on 2/12/2016
  • FINANCIAL NEWS: Gene therapy play Bamboo raises $49.5M

    Bamboo Therapeutics Inc. (Chapel Hill, N.C) raised $49.5 million in a series A round. Bamboo Co-Founder and CEO Sheila Mikhail declined to name any of the investors except CureDuchenne Ventures LLC, whose investment was…

    Published on 2/12/2016
  • FINANCIAL NEWS: Shield raises L32.5M in LSE IPO

    Shield Therapeutics plc (LSE:STX) raised L32.5 million ($47.1 million) through the sale of 21.7 million shares at 150p in an IPO on the London Stock Exchange. The company said its market capitalization will be L162.2 …

    Published on 2/12/2016
  • FINANCIAL NEWS: AveXis, Proteostasis dip after IPOs

    Gene therapy company AveXis Inc. (NASDAQ:AVXS) and respiratory company Proteostasis Therapeutics Inc. (NASDAQ:PTI) both posted losses in their first day of trading Thursday after pricing IPOs.AveXis fell $1.95 (10%) to…

    Published on 2/11/2016
  • FINANCIAL NEWS: M3 raises $10M in series A

    M3 Biotechnology Inc. (Seattle, Wash.) raised $10 million in an oversubscribed series A round. Brothers Bruce and Michael Montgomery invested alongside W-Fund, WRF Capital, John Fluke and Dolby Family Ventures.CEO Leen …

    Published on 2/11/2016
  • FINANCIAL NEWS: Cancer play Armo raises $50M series C

    Armo BioSciences Inc. (Redwood City, Calif.) raised $50 million in a series C round. Existing investors Kleiner Perkins Caufield & Byers, OrbiMed, DAG Ventures and NanoDimension were joined by new investors HBM …

    Published on 2/10/2016
  • FINANCIAL NEWS: Yumanity raises $45M series A

    Yumanity Therapeutics LLC (Cambridge, Mass.) raised $45 million in a series A round led by Fidelity. Redmile Group, Alexandria Venture Investments, Biogen Inc. (NASDAQ:BIIB), Sanofi-Genzyme BioVentures and Dolby Family …

    Published on 2/10/2016
  • FINANCIAL NEWS: Actelion looks beyond PAH as sales top CHF2B

    Actelion Ltd. (SIX:ATLN) reported 2015 product sales of CHF2.05 billion ($2.06 billion), crossing the CHF2 billion ($2.02 billion) threshold for the first time. Sales were up 7% at constant exchange rates from CHF1.96 …

    Published on 2/9/2016
  • FINANCIAL NEWS: Regeneron falls after reporting earnings

    Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) shed $24.56 to $365.97 on Tuesday after reporting 4Q15 and 2015 financial results that missed expectations and guiding to slower growth of 2016 U.S. sales of ophthalmic drug …

    Published on 2/9/2016
  • FINANCIAL NEWS: Cellular Biomedicine secures $43.1M from Dangdai

    Cell therapy company Cellular Biomedicine Group Inc. (NASDAQ:CBMG) is raising $43.1 million through the sale of 2.3 million shares at $19 to Wuhan Dangdai Science and Technology Industries Group. The purchase price is a…

    Published on 2/5/2016
  • FINANCIAL NEWS: Imperial Innovations looks to raise L100M

    Imperial Innovations Group plc (LSE:IVO) plans to raise L100 million ($142.9 million) through a placing of 23.5 million shares at 425p to existing and new institutional investors. The price is a 6% premium to the firm's…

    Published on 2/4/2016
  • FINANCIAL NEWS: KemPharm raises $75M

    Prodrug developer KemPharm Inc. (NASDAQ:KMPH) raised $75 million through the sale of senior unsecured notes in a deal led by Deerfield Management. Book-running managers were Cowen and RBC Capital Markets, and co-…

    Published on 2/4/2016
  • FINANCIAL NEWS: Alexion reports on Strensiq, Kanuma launches

    Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) gained $8.61 to $145.97 Wednesday after reporting 4Q15 and full-year earnings, including early sales of Strensiq asfotase alfa and Kanuma sebelipase alfa.The company reported $…

    Published on 2/3/2016
  • FINANCIAL NEWS: Anti-aging company Unity makes debut

    Unity Biotechnology (San Francisco, Calif.) made its debut on Wednesday with an investment of undisclosed size from Arch Venture Partners, Venrock, WuXi, Mayo Clinic, Unity's management team and undisclosed investors. …

    Published on 2/3/2016
  • FINANCIAL NEWS: Enyo secures EUR 22M to treat viral infections

    Enyo Pharma S.A.S. (Paris, France) raised EUR 6 million ($6.5 million) in the first tranche of a planned EUR 22 million ($23.9 million) series A round led by its seed investor, Sofinnova Partners. Morningside and …

    Published on 2/3/2016
  • FINANCIAL NEWS: LAM closes $40M financing

    LAM Therapeutics (Guilford, Conn.) said it raised $40 million in a venture round from undisclosed investors. The company develops therapeutics for cancer and rare diseases. President and CSO Henri Lichenstein told …

    Published on 2/3/2016
  • FINANCIAL NEWS: Pierre Fabre launches early stage research initiative

    Laboratoires Pierre Fabre S.A. (Castres, France) launched the Pierre Fabre Fund for Innovation, a new strategic initiative through which it will support early stage research programs in dermatology and oncology with the…

    Published on 2/3/2016
  • FINANCIAL NEWS: Index spins out Medicxi Ventures

    Medicxi Ventures debuted on Tuesday with a EUR 210 million ($227.9 million) fund that will focus on early stage life science investments in Europe. Medicxi comprises the life sciences team, funds and portfolio companies…

    Published on 2/2/2016
  • FINANCIAL NEWS: Kadmon mum on IPO rumors

    Kadmon Corp. LLC (New York, N.Y.) did not respond to requests for comment on media reports that said the biotech may file for an IPO as early as this week. IPO signals are nothing new to the company, and date back to …

    Published on 2/2/2016
  • FINANCIAL NEWS: Mission Therapeutics raises L60M

    Mission Therapeutics Ltd. (Cambridge, U.K.) secured L60 million ($85.7 million) in a tranched series C round co-led by existing investor Imperial Innovations Group plc (LSE:IVO) and new investor Woodford Investment …

    Published on 2/2/2016
  • FINANCIAL NEWS: Qiming closes Fund V at $648 million

    Qiming Venture Partners closed its Qiming V fund at $648 million. As with past funds, Qiming will invest Fund V in Chinese healthcare, IT, cleantech, internet and consumer companies, with more than 50% of its …

    Published on 2/2/2016
  • FINANCIAL NEWS: Spero closes $30M series B round

    Anti-infective play Spero Therapeutics LLC (Cambridge, Mass.) secured $30 million in a tranched series B round from existing investors Atlas Venture, SR One, MRL Ventures, Lundbeckfond Ventures, the Kraft Group and …

    Published on 2/2/2016
  • FINANCIAL NEWS: Sinovac mulls take-private proposal

    Sinovac Biotech Ltd. (NASDAQ:SVA) gained $0.78 (16%) to $5.80 on Monday after it received a non-binding proposal from President and CEO Weidong Yin and existing shareholder SAIF Partners to acquire all outstanding …

    Published on 2/1/2016
  • FINANCIAL NEWS: AbbVie reports 4Q15 results

    AbbVie Inc. (NYSE:ABBV) reported 4Q15 and 2015 financial results Friday that were in-line with consensus estimates, although its U.S. 4Q sales of HCV regimen Viekira Pak missed expectations. U.S. Viekira sales were $197…

    Published on 1/29/2016
  • FINANCIAL NEWS: Financial tracks

    Frazier Healthcare Partners named Anthony Draye executive partner on its growth buyout team. Draye was director of applications for TridentUSA Health Services (Glencoe, Md.).Tech transfer and investment firm …

    Published on 1/29/2016

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993